Preliminary normal reference values of nuchal translucency thickness in Taiwanese fetuses at 11-14 weeks of gestation

Chang Gung Medical Journal

Volumn 26, Issue 1, 2003, Pages 12-19

  Hsu, Jenn Jeih ^a   Hsieh, Ching Chang ^a   Chiang, Chi Hsin ^a   Lo, Liang Ming ^a   Hsieh, T'sang T'ang ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Crown rump length (CRL); Down's syndrome screening; Multiple of median (MoM); Nuchal translucency

Indexed keywords

ARTICLE; CALCULATION; CONTROLLED STUDY; CROWN RUMP LENGTH; DIAGNOSTIC IMAGING; FETUS; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MATERNAL AGE; NORMAL DISTRIBUTION; PRENATAL SCREENING; PROSPECTIVE STUDY; RACE DIFFERENCE; REFERENCE VALUE; RISK ASSESSMENT; TAIWAN; TRISOMY 21;

ADULT; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HUMANS; PREGNANCY; PROSPECTIVE STUDIES; REFERENCE VALUES; ULTRASONOGRAPHY, PRENATAL;

EID: 0037235222     PISSN: 02558270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. Br Med J 1992;304:867-9.
2. Nicolaides KH, Brizot ML, Snijders RJ. Fetal nuchal translucency thickness: ultrasound screening for fetal trisomy in the first trimester of pregnancy. Br J Obstet Gynaecol 1994;101:782-6.
3. Brambati B, Cislaghi C, Tului L, Alberti E, Amidani M, Colombo U, Zuliani G. First-trimester Down's syndrome screening using nuchal translucency: a prospective study in patients undergoing chorionic villus sampling. Ultrasound Obstet Gynecol 1995;5:9-14.
4. Wald NJ, George L, Smith D, Densem JW, Petterson K. Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. Br J Obstet Gynaecol 1996;103:407-12.
5. Snijders RJM, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Lancet 1998;352:343-6.
6. Hsu JJ, Chiu CH, Hsieh CC, Hsieh TT. The application of fetal nuchal translucency in the detection of chromosomal abnormalities during the first trimester in an Asian population. Ultrasound Obstet Gynecol 1997;14(suppl 1):252.
7. Jauniaux E, Brown R, Snijders RJM, Noble P, Nicolaides KH. Early prenatal diagnosis of triploidy. Am J Obstet Gynecol 1997;176:550-4.
8. Wald NJ, Hackshaw AK, Watt H. Nuchal translucency and trisomy 18. Prenat Diagn 1999;19:995-6.
9. Snijders RJ, Johnson S, Sebire NJ, Noble PL, Nicolaides KH. First-trimester ultrasound screening for chromosomal defects. Ultrasound Obstet Gynecol 1996;7:216-26.
10. Hyett J, Perdu M, Sharland G, Snijders R, Nicolaides KH. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study. Br Med J 1999;318:81-5.
11. Souka AP, Snijders RJM, Novakov A, Soares W, Nicolaides KH. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation. Ultrasound Obstet Gynecol 1998;11:391-400.
12. Pandya PP, Snijders RJ, Johnson S, Brizot ML, Nicolaides KH. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation. Br J Obstet Gynaecol 1995;102:957-62.
13. Scott F, Boogert A, Sinosich M, Anderson J. Establishment and application of a normal range for nuchal translucency across the first trimester. Prenat Diagn 1996;16:629-34.
14. Pajkrt E, Mol BWJ, van Lith JMM, Bleker OP, Bilardo CM. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population. Ultrasound Obstet Gynecol 1998;12:163-9.
15. Pajkrt E, de Graaf IM, Mol BWJ, van Lith JMM, Bleker OP, Bilardo CM. Weekly nuchal translucency measurements in normal fetuses. Obstet Gynecol 1998;91:208-11.
16. Thilaganathan B, Khare M, Williams B, Wathen NC. Influence of ethnic origin on nuchal translucency screening for Down's syndrome. Ultrasound Obstet Gynecol 1998;12:112-4.
17. Moscoso G. Fetal nuchal translucency: a need to understand the physiological basis. Ultrasound Obstet Gynecol 1995;5:6-8.
18. Jauniaux E, Burton GL, Moscoso G. Development of the early placenta: a morphometric study. Placenta 1991; 12:269-76.
19. Vuillemin M, Pexider T, Winking H. Pathogenesis of various forms of double outlet right ventricle in mouse fetal trisomy 13. Int Cardio J 1991;33:281-304.
20. DeVore GR. Trisomy 21: 91% detection rate using second-trimester ultrasound markers. J Ultrasound Med 2001;16:133-41.
21. Jou HJ, Wu SC, Li TC, Hsu HC, Tzeng CY, Hsieh FJ. Relationship between fetal nuchal translucency and crown-rump length in an Asian population. Ultrasound Obstet Gynecol 2001;17:111-4.
22. Whitlow BJ, Economides DL. The optimal gestational age to examine fetal anatomy and measure nuchal translucency in the first trimester. Ultrasound Obstet Gynecol 1998;11:258-61.
23. Braithwaite JM, Armstrong MA, Economides DL. Assessment of fetal anatomy at 12 to 13 weeks of gestation by transabdominal and transvaginal sonography. Br J Obstet Gynaecol 1996;103:82-5.
24. Pandya PP, Snijders RJ, Johnson S, Nicolaides KH. Natural history of trisomy 21 fetuses with increased nuchal translucency thickness. Ultrasound Obstet Gynecol 1995;5:381-3.
25. Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 1999;13:1-7.
26. Schuchter K, Wald N, Hackshaw AK, Hafner E, Liebhart E. The distribution of nuchal translucency at 10-13 weeks of pregnancy. Prenat Diagn 1998;18:281-6.
27. Parker AJ, Davies P, Newton JR. Assessment of gestational age of the Asian fetus by the sonar measurement of crown-lump length and biparietal diameter. Br J Obstet Gynaecol 1982;89:836-8.